Puma Biotechnology (PBYI) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $6.6 million.
- Puma Biotechnology's Accumulated Depreciation & Amortization fell 1737.93% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 1737.93%. This contributed to the annual value of $7.9 million for FY2024, which is 244.79% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's Accumulated Depreciation & Amortization is $6.6 million, which was down 1737.93% from $8.1 million recorded in Q2 2025.
- Puma Biotechnology's 5-year Accumulated Depreciation & Amortization high stood at $8.1 million for Q2 2025, and its period low was $6.3 million during Q1 2021.
- For the 5-year period, Puma Biotechnology's Accumulated Depreciation & Amortization averaged around $7.4 million, with its median value being $7.6 million (2023).
- Per our database at Business Quant, Puma Biotechnology's Accumulated Depreciation & Amortization surged by 1154.28% in 2021 and then plummeted by 1737.93% in 2025.
- Puma Biotechnology's Accumulated Depreciation & Amortization (Quarter) stood at $6.9 million in 2021, then rose by 8.23% to $7.4 million in 2022, then grew by 3.42% to $7.7 million in 2023, then rose by 2.45% to $7.9 million in 2024, then decreased by 16.26% to $6.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $6.6 million for Q3 2025, versus $8.1 million for Q2 2025 and $8.0 million for Q1 2025.